101 March 11, 2026 On February 20, 2026, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision regarding recombinant DNA subject-matter eligibility, reversing a decision by the ...
Squires clarified the USPTO policies regarding Section 101 patentability in the case of advanced technologies, including blockchain, artificial intelligence and medical diagnosis. In an "Open Letter" ...
How you Do It May Lead to Invalidity under Section 101 October 5, 2022 Integrated Technology Solutions, LLC (“ITS”) alleged that products manufactured and distributed by iRacing.com Motorsport ...
PTAB Reverses §101 and §103 Rejections for Plant Extract December 13, 2022 Update by Grace Kim and Sara Pistilli, PharmD. On December 6, 2022, the Patent Trial and Appeal Board (PTAB) overturned ...
Communications Channel Are Patent Ineligible under Section 101 August 23, 2021 Plaintiff Zyrcuits IP LLC has sued Defendants Acuity Brands, Inc. and Universal Electronics Inc. for infringement of claim ...
and Patent Eligibility Under Section 101 March 30, 2020 Before LOURIE, MOORE, and REYNA, Circuit Judges. Illumina, Inc. and Sequenom, Inc. (“Illumina”) filed suit against Ariosa Diagnostics, Inc....
101 Author: David Inglefield March 11, 2026 On February 20, 2026, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision regarding recombinant DNA subject-matter eligibility, ...
101. The CAFC found that the claims were indeed related to concrete structures, not patent-ineligible abstract ideas, and affirmed the lower court’s finding regarding enablement.<... Read more Patenting ...
101 Author: David Inglefield March 11, 2026 On February 20, 2026, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision regarding recombinant DNA subject-matter eligibility, ...
101 Author: David Inglefield March 11, 2026 On February 20, 2026, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision regarding recombinant DNA subject-matter eligibility, ...